
Sign up to save your podcasts
Or


In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.
Medical terminology referenced in this episode:
Questions or comments?
Email us at [email protected].
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
By Mark Hansan and Dr. Scott Howell5
2020 ratings
In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.
Medical terminology referenced in this episode:
Questions or comments?
Email us at [email protected].
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

4,164 Listeners

238 Listeners

112,360 Listeners

494 Listeners

322 Listeners

23,506 Listeners

34 Listeners

57,845 Listeners

44 Listeners

8,717 Listeners

1,198 Listeners